We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Osthole represses growth of multiple myeloma cells by regulating PI3K/AKT and ERK pathways.
- Authors
Lingling Huang; Xiaofeng Zhao; Zhengmei He; Lizhong Guo
- Abstract
Purpose: To identify the effects of osthole on the growth of multiple myeloma cells and determine the probable molecular mechanism of action. Methods: 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide (MTT) assay was used to measure multiple myeloma cell viability. Flow cytometry was used for the evaluation of cell cycle and apoptosis. For protein expression measurement, western blot analysis was employed. Results: The results show that osthole dose- and time-dependently suppressed the viability of multiple myeloma cells (p < 0.01). Osthole also dose-dependently initiated multiple myeloma cell cycle arrest in G0/G1 phase (p < 0.05) and induced multiple myeloma cell apoptosis (p < 0.01). Moreover, western blotting revealed a significant reduction in cyclin D1 (p < 0.01) and induction in p21, cleaved caspase 3 and cleaved poly (ADP-ribose) polymerase (p < 0.01). Furthermore, osthole treatment significantly downregulated the phosphorylation levels of protein kinase B (AKTT308), AKTS473, and extracellular regulated protein kinase 1/2 (ERK1/2). Conclusion: These findings demonstrated that osthole inhibited viability and induced cell cycle arrest and apoptosis of multiple myeloma cells by regulating PI3K/AKT and ERK pathways. Osthole may be considered as a potential anticancer agent for the therapy of multiple myeloma.
- Subjects
MULTIPLE myeloma; PROTEIN kinase B; WESTERN immunoblotting; CELL cycle; PROTEIN kinases
- Publication
Tropical Journal of Pharmaceutical Research, 2019, Vol 18, Issue 11, p2287
- ISSN
1596-5996
- Publication type
Article
- DOI
10.4314/tjpr.v18i11.8